Articles

Agilent teams with Picometrics Technologies to offer analytical solutions for biopharmaceutical applications

Agilent Technologies Inc. has signed a co-marketing agreement with Picometrics Technologies to provide biopharmaceutical customers with combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection and mass spectrometry
Written byLloyd Dunlap
| 3 min read

SANTA CLARA, Calif.—Agilent Technologies Inc. has signed a co-marketing agreement with Picometrics Technologies to provide biopharmaceutical customers with combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection and mass spectrometry.

In addition to classic CE-LIF analysis technology, this collection of tools provides the only online CE-LIF-MS solution available today, the company stated in a news release. The platform’s principal application is for the research and development of complex large-molecule biopharmaceutical compounds.

“We are very pleased to extend a long-standing and fruitful partnership with Agilent and consolidate our development strategy,” said Jean Charles Garcia, president of Picometrics. “This unique technological platform using our new-generation LIF detection will significantly increase efficiency for biotherapeutic characterization in research, development and quality control.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Abstract rainbow-colored beams of light spreading across a dark background.
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
3D illustration of protein receptors embedded in a cell membrane interacting with small molecules.
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.